News

July – Novoron Bioscience Teams Up with Expesicor to Develop Neuro-regenerative Compounds for Epilepsy and Alzheimer’s Disease

April – Patent Filed – A method for preventing and treating tauopathies

Dec – Patent Filed

Oct – New Expesicor office in Missoula, MT

July – Expesicor receives a grant from the Montana Department of Commerce

May – Patent Filed – A method to prevent the development of brain injury-induced seizure disorders

May – Patent Filed – A novel molecular imaging method to assess sudden death risk

February 3 – A peer-reviewed study demonstrating the significant advantages of the KaL Model™ was published in this month’s Epilepsia

Dec 28 – Patent Filed

June – First private loan to Expesicor

Mar 31 – Expesicor Formed